Difference between revisions of "C-CDA Implementation-a-Thon 1"
(15 intermediate revisions by 4 users not shown) | |||
Line 1: | Line 1: | ||
− | + | Return to [[Structured Documents TC|SDWG]] page. | |
+ | |||
+ | Return to [[C-CDA: Enhancing Implementation (ONC Grant Project)]] page. | ||
+ | |||
+ | Return to [[C-CDA 2.1 Companion Guide Project]] page. | ||
January 7-8, 2016 | January 7-8, 2016 | ||
Line 13: | Line 17: | ||
*Nagesh Bashyam aka Dragon (ONC) | *Nagesh Bashyam aka Dragon (ONC) | ||
*Dr. Julia Skapic (ONC) | *Dr. Julia Skapic (ONC) | ||
+ | *Calvin Beebe (Mayo Clinic) | ||
*Ben Flessner and Dave Sundaram-Stukel (Epic) | *Ben Flessner and Dave Sundaram-Stukel (Epic) | ||
*Dave Camp, Peter James and Kenny Tomlinson (Wellcentive) | *Dave Camp, Peter James and Kenny Tomlinson (Wellcentive) | ||
Line 27: | Line 32: | ||
*Dante Hoyte (USF) | *Dante Hoyte (USF) | ||
*Mario Nears (USF) | *Mario Nears (USF) | ||
+ | *Calvin Beebe (Mayo) | ||
=Agenda= | =Agenda= | ||
Line 128: | Line 134: | ||
| | | | ||
* There are multiple places to record medication information (e.g. Medications, Admission Medications, Discharge Medications, etc.). It would be good to clarify which sections are used in which circumstances. | * There are multiple places to record medication information (e.g. Medications, Admission Medications, Discharge Medications, etc.). It would be good to clarify which sections are used in which circumstances. | ||
− | * Because document templates are open, it appears that one could legally use a CCD and add discharge summary sections (e.g. discharge medications) for discharge summary usage scenarios. | + | * Because document templates are open, it appears that one could legally use a CCD and add discharge summary sections (e.g. discharge medications) for discharge summary usage scenarios. It would be good to provide clarification on how discharge summary information should be structured in the Companion Guide. |
* It is important to remember that there is a different context for medications, admission medications, administered medications and discharge medications. Important to have guidance on when to use which and if it is appropriate to "repeat" information for the sake of adding sections to meet certification requirements. Could the use of subsections help this? Unclear as there is no guidance to vendors in terms of how section/subsection information should be consumed or displayed to end users. | * It is important to remember that there is a different context for medications, admission medications, administered medications and discharge medications. Important to have guidance on when to use which and if it is appropriate to "repeat" information for the sake of adding sections to meet certification requirements. Could the use of subsections help this? Unclear as there is no guidance to vendors in terms of how section/subsection information should be consumed or displayed to end users. | ||
* Common misunderstanding of what information should be in procedures sections vs. what information should be in results section. | * Common misunderstanding of what information should be in procedures sections vs. what information should be in results section. | ||
Line 171: | Line 177: | ||
[[File:Discharge Summary - Full version 2.doc]] | [[File:Discharge Summary - Full version 2.doc]] | ||
+ | |||
+ | |||
+ | =Deliverables/Documents= | ||
+ | *[http://gforge.hl7.org/gf/download/docmanfileversion/9038/13829/%49%6d%70%6c%65%6d%65%6e%74%61%74%69%6f%6e%2d%61%2d%54%68%6f%6e%20%31%20%45%76%65%6e%74%20%53%75%6d%6d%61%72%79%2e%70%64%66 Implementation-A-Thon 1 Summary Report] |
Latest revision as of 13:32, 20 July 2016
Return to SDWG page.
Return to C-CDA: Enhancing Implementation (ONC Grant Project) page.
Return to C-CDA 2.1 Companion Guide Project page.
January 7-8, 2016 UCF Executive Development Centre Orlando, Florida
Contents
Attendees
- Joginder Madra (Facilitator)
- Jean Duteau (Facilitator)
- Dave Hamill (HL7)
- Karen van Hentenryck (HL7)
- Matt Rahn (ONC)
- Nagesh Bashyam aka Dragon (ONC)
- Dr. Julia Skapic (ONC)
- Calvin Beebe (Mayo Clinic)
- Ben Flessner and Dave Sundaram-Stukel (Epic)
- Dave Camp, Peter James and Kenny Tomlinson (Wellcentive)
- Raychelle Fernandez and Ozlem Kurt (Dynamic Health IT)
- Dave Carlson (Mieweb)
- Lisa Nelson (Life over Time Solutions)
- Joe Lamy (Aegis / Sequoia)
- Russ Leftwich (Intersystems)
- George Cole (Allscripts)
- Angel Pinzon (APS Puerto Rico)
- Linda Michaelsen (Optum)
- Luis Jimenez, Michelet Boursiquot, Clint Walker, and Luis Silva (Document Storage Systems)
- Dmitry Shalamov (NextGen)
- Dante Hoyte (USF)
- Mario Nears (USF)
- Calvin Beebe (Mayo)
Agenda
Thursday, January 7, 2016
- 0900-1000 Introductions
- 1000-1200 CCD Testing
- 1200-1300 Lunch
- 1300-1400 CCD Testing (ctnd)
- 1400-1700 Discharge Summary Testing
Friday, January 8, 2016
- 0900-1200 Referral Note Testing
- 1200-1300 Lunch
- 1300-1500 Discussion about Testing
- 1500-1600 Discussion about next IaT
Discussion Items
Item | Notes |
---|---|
Introductions / Housekeeping |
|
CCD Scenarios |
Receiver discussion:
Creator discussion:
Q: How should text-only narratives (e.g. no medication entries) be handled in the receiving systems UI? A: These should always be included. Certification rules are expected to follow the gold standard set by the Examples Task Force. Certification tests also provide the explicit codes to use...i.e. test data is fixed. |
Ask the ONC |
Q: What is the source of truth for value sets? Some are obvious, but some are challenging to discern who is the authority. A: If it is in VSAC, certification will use it (approved only). ONC is working with closely with VSAC. Q: Will it be a problem for testing if systems add translations to the expected codes? A: As long as the expected code is sent, sending the translation will not be an issue Q: How is errata handled by the validators - e.g. some validators (i.e. QRDA vs. C-CDA) have incorporated the errata and others have not? A: Send email to ONC inbox to raise the issue. The SITE validator is intended to go above and beyond what is required for certification Q: How are people handling CCDS requirements that are not in the C-CDA document templates? A: People are adding them anyways...as the interpretation is that those sections are always required. Q:What is the CDA extension source of truth? A: The full extension schema is posted to gforge and is accessible via the HL7 wiki. This is no longer shipping with C-CDA...implementers must get the latest from the repository |
Discharge Summary Scenarios |
Q: Is there a way to evaluate to how instances have been consumed (e.g. for accuracy, etc.)? A: One option could be to for receiving systems to create a PDF and note any inconsistencies. |
Day Two |
|
Receiver Processing |
Receivers took turns showing how the samples created during day 1 were consumed by their system. General observations:
General comments:
|
Common Clinical Data Set Discussion |
Q: Will HL7 be using the ONC 2016 rules? A: The 2016 rules represent the newest final rules. The Companion Guide project will be issuing guidance as per the 2016 rules. |
De-Brief and Wrap Up |
|
Scenario Files
CCD
File:HL7 IAT 1 CCD Scenario - CCDS.doc
File:HL7 IAT 1 CCD Scenario - Full.doc
Discharge Summary
File:Discharge Summary - CCDS.doc
File:Discharge Summary - Full.doc
File:Discharge Summary - Full version 2.doc